---
schema_version: "secwatch.filing_event.v1"
accession: "0001554859-24-000013"
form_type: "8-K"
ticker: null
cik: "0001554859"
company_name: "Semler Scientific, Inc."
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T18:09:58.255275+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Semler Scientific Q1 revenue down 13% to $15.9M; net income up 22% to $6.1M

## Summary
- Revenue of $15.9M, down 13% YoY; fixed-fee software license revenue fell 24% to $7.1M.
- Net income of $6.1M ($0.78 diluted EPS) vs. $5.0M ($0.63) a year ago; operating expenses dropped 25%.
- Cash and equivalents grew to $62.9M from $57.2M at year-end 2023, driven by strong cash generation.
- CEO cites regulatory-driven revenue decline from PAD product; expects re-acceleration if new FDA 510(k) is obtained.
- Three largest customers comprised 45%, 25%, and 11% of Q1 2024 revenue.

## SEC filing metadata
- accession: 0001554859-24-000013
- form_type: 8-K
- cik: 0001554859
- company_name: Semler Scientific, Inc.
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1554859/000155485924000013/0001554859-24-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1554859/000155485924000013/smlr-20240507x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001554859-24-000013
- JSON: https://secwatch.observer/filing/0001554859-24-000013.json
- Plain text: https://secwatch.observer/filing/0001554859-24-000013.txt

## Key facts
- Earnings Releases
  Semler Scientific, Inc. reported first quarter ended March 31, 2024 results: revenue $15.9 million, net income $6.1 million, EPS $0.88 per basic share and $0.78 per diluted share.
  - Period: first quarter ended March 31, 2024
  - Revenue: $15.9 million
  - Net income: $6.1 million
  - EPS: $0.88 per basic share and $0.78 per diluted share
  - Result: reported results
  source text: (EX-99.1) --- Semler Scientific® Reports First Quarter 2024 Financial Results 2024 Q1 highlights compared to the corresponding period of 2023: ​ ● First quarter revenues were $15.9 million, a decrease of 13% ● First quarter net income was $6.1 million, an increase of 22% ● Cash, cash equivalents and restricted cash balance increased to $62.9 million ​ S anta Clara,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1554859/000155485924000013/0001554859-24-000013-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.